Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adel Haque

Dermatology Yardley, PA Medical Doctor

NPI 1760913511 CMS profile 5702530

209 Floral Vale Blvd, Yardley, PA 19067

Open in the dashboard

General payments

$1,008,383

1,644 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adel Haque of Yardley, PA is reported in the CMS Open Payments database as having received $1,008,383 across 1,644 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $524,463 546
2024 General $292,016 502
2023 General $173,163 355
2022 General $17,955 212
2021 General $455 25
2020 General $18 1
2019 General $313 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adel Haque
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Adel Haque were reported at $524,463. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Adel Haque Dermatology median Middle half National median
2019 $313 $454 $129–$1,240 $163
2020 $18 $235 $81–$756 $114
2021 $455 $377 $108–$1,108 $132
2022 $17,955 $514 $143–$1,391 $149
2023 $173,163 $607 $159–$1,674 $160
2024 $292,016 $751 $204–$1,903 $164
2025 $524,463 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $160,992 324 payments
  2. Regeneron Healthcare Solutions, Inc. $149,065 147 payments
  3. Janssen Biotech, Inc. $130,372 227 payments
  4. Lilly USA, LLC $110,762 157 payments
  5. Galderma Laboratories, L.P. $86,185 77 payments
  6. Botanix SB Inc $78,482 49 payments
  7. Amgen Inc. $66,455 91 payments
  8. Organon LLC $61,529 54 payments
  9. UCB, Inc. $51,053 67 payments
  10. Genzyme Corporation $50,124 54 payments
  11. Other $63,363 397 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $799,358 236 payments
  2. Consulting Fee $60,094 22 payments
  3. Honoraria $55,200 14 payments
  4. Travel and Lodging $45,541 223 payments
  5. Food and Beverage $33,478 1,141 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $14,440 4 payments
  7. Education $272 4 payments
Products named General payments · program years 2019–2025
  1. TREMFYA $130,349 226 payments
  2. EBGLYSS $111,534 102 payments
  3. SKYRIZI $106,279 184 payments
  4. NEMLUVIO $85,926 64 payments
  5. SOFDRA $78,482 49 payments
  6. VTAMA $70,575 92 payments
  7. DUPIXENT Inflammation And Immunology $67,952 78 payments
  8. Otezla $66,455 91 payments
  9. DUPIXENT Immunology And Inflammation $62,086 57 payments
  10. DUPIXENT Immunology $50,174 56 payments
  11. Other $127,508 696 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,644 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record